{"filings":[{"id":583516,"accession_number":"0001022079-26-000052","cik":1022079,"company_name":"QUEST DIAGNOSTICS INC","ticker":"DGX","form_type":"8-K","filed_at":"2026-05-21T20:48:35+00:00","items":["5.07"],"status":"ready","headline":"Quest Diagnostics elects all 11 director nominees; stockholder proposal on independent chairman rejected","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All 11 director nominees elected; Timothy M. Ring received 81.9M for, 12.0M against (lowest support).","Advisory say-on-pay resolution approved: 86.9M for, 7.2M against.","Ratification of PwC as auditor approved: 97.3M for, 5.8M against.","Stockholder proposal for independent board chairman rejected: 24.0M for, 69.8M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":21474000299.405693,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":90653,"accession_number":"0001104659-26-057938","cik":1022079,"company_name":"QUEST DIAGNOSTICS INC","ticker":"DGX","form_type":"8-K","filed_at":"2026-05-08T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Quest Diagnostics issues $500M of 5.000% senior notes due 2036","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$500M aggregate principal, 5.000% coupon, maturity June 30, 2036.","Interest payable semi-annually on June 30 and Dec 30, beginning Dec 30, 2026.","Senior unsecured, ranks equally with existing senior debt; no sinking fund.","Upon a change of control triggering event, repurchase at 101% plus accrued interest.","Issued under existing indenture as supplemented by twenty-fourth supplemental indenture."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":21474000299.405693,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":90652,"accession_number":"0001104659-26-054141","cik":1022079,"company_name":"QUEST DIAGNOSTICS INC","ticker":"DGX","form_type":"8-K","filed_at":"2026-05-01T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Quest Diagnostics prices $500M of 5.000% senior notes due 2036","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$500M aggregate principal of 5.000% senior notes due 2036 priced under shelf registration.","Net proceeds for general corporate purposes, may repay $500M 3.45% notes maturing June 1, 2026.","Closing expected May 6, 2026, subject to customary closing conditions.","Underwriting agreement with Goldman Sachs, J.P. Morgan, and Mizuho Securities."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":21474000299.405693,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":90651,"accession_number":"0001022079-26-000040","cik":1022079,"company_name":"QUEST DIAGNOSTICS INC","ticker":"DGX","form_type":"8-K","filed_at":"2026-04-21T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quest Diagnostics Q1 revenue $2.90B (+9.2%), raises FY2026 EPS and revenue guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Reported diluted EPS $2.24 (+15.5%); adjusted diluted EPS $2.50 (+13.1%).","Requisition volume up 10.9% organic; revenue per requisition down 1.3%.","FY2026 adjusted EPS guidance raised to $10.63-$10.83 from $10.50-$10.70; revenue now $11.78-$11.90B.","Operating income margin improved to 15.4% adjusted; cash from ops $278M."],"consensus_eps_estimate":null,"consensus_eps_actual":2.24,"consensus_revenue_estimate":null,"consensus_revenue_actual":2895000000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":21474000299.405693,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":100348,"accession_number":"0000947871-26-000244","cik":1022079,"company_name":"QUEST DIAGNOSTICS INC","ticker":"DGX","form_type":"8-K","filed_at":"2026-03-12T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Quest Diagnostics elects former Walgreens CEO Timothy Wentworth to board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Elected Timothy Wentworth, former CEO of Walgreens Boots Alliance, as director effective March 9, 2026.","Appointed to Compensation and Leadership Development and Quality and Compliance Committees.","Received prorated restricted share unit grant valued at approximately $43,000 upon joining board.","Board now consists of 11 members including Wentworth.","Wentworth also previously CEO of Evernorth Health Services and Express Scripts."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":21474000299.405693,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":100347,"accession_number":"0001022079-26-000005","cik":1022079,"company_name":"QUEST DIAGNOSTICS INC","ticker":"DGX","form_type":"8-K","filed_at":"2026-02-10T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Quest Diagnostics Q4 rev $2.81B (+7.1%), adj EPS $2.42 (+8.5%); raises dividend 7.5%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["FY2025 revenue $11.04B (+11.8%), reported EPS $8.75 (+13.8%), adjusted EPS $9.85 (+10.3%).","Q4 organic requisition volume +7.9%; operating cash flow $465M; FY cash from ops $1.89B.","FY2026 guidance: revenue $11.70B-$11.82B, adjusted EPS $10.50-$10.70.","Quarterly dividend raised 7.5% to $0.86/share, payable Apr 20, 2026 to holders of record Apr 6, 2026.","Board authorized additional $1B share repurchase; $0.4B remained from prior program."],"consensus_eps_estimate":null,"consensus_eps_actual":8.75,"consensus_revenue_estimate":null,"consensus_revenue_actual":11035000000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":21474000299.405693,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":100346,"accession_number":"0000947871-26-000025","cik":1022079,"company_name":"QUEST DIAGNOSTICS INC","ticker":"DGX","form_type":"8-K","filed_at":"2026-01-12T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Quest Diagnostics presents at J.P. Morgan Healthcare Conference; no new financial details disclosed","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Presentation at 44th Annual J.P. Morgan Healthcare Conference on Jan 12, 2026.","Discussed strategy, performance, market developments and trends; no specific financial details.","No new quantitative updates, guidance, or targets in the filed presentation materials.","Presentation includes standard forward-looking statements and risk factors."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":21474000299.405693,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116681,"accession_number":"0001022079-25-000219","cik":1022079,"company_name":"QUEST DIAGNOSTICS INC","ticker":"DGX","form_type":"8-K","filed_at":"2025-10-21T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quest Diagnostics Q3 revenue $2.82B (+13.1%), raises FY2025 adjusted EPS guidance to $9.76–$9.84","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 reported diluted EPS $2.16 (+8.5%); adjusted diluted EPS $2.60 (+13.0%) vs $2.30 prior year.","Revenue up 13.1% to $2.82B with 6.8% organic growth; diagnostic info services revenue $2.76B.","FY2025 adjusted EPS guidance raised to $9.76–$9.84 from $9.63–$9.83; revenue guidance raised to $10.96B–$11.00B.","Year-to-date cash from operations $1.42B, up 63.1%; Co-Lab Solutions annual revenue run-rate ~$1B expected next year.","Announced lab services JV with Corewell Health; acquired dialysis testing assets from Fresenius Medical Care."],"consensus_eps_estimate":null,"consensus_eps_actual":6.57,"consensus_revenue_estimate":null,"consensus_revenue_actual":8229000000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":21474000299.405693,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133124,"accession_number":"0001022079-25-000172","cik":1022079,"company_name":"QUEST DIAGNOSTICS INC","ticker":"DGX","form_type":"8-K","filed_at":"2025-07-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quest Diagnostics Q2 revenues $2.76B (+15.2%), beats; raises FY2025 adjusted EPS guidance to $9.63-$9.83","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenue $2.76B, up 15.2% YoY; organic revenue growth 5.2%.","Reported diluted EPS $2.47 (+21.7%); adjusted diluted EPS $2.62 (+11.5%).","Cash from operations $544M in Q2 (+51.5%); YTD $858M (+67.1%).","Raises full-year 2025 net revenue guidance to $10.80B-$10.92B (from $10.70B-$10.85B).","FY2025 adjusted diluted EPS guidance raised to $9.63-$9.83 from $9.55-$9.80."],"consensus_eps_estimate":null,"consensus_eps_actual":4.41,"consensus_revenue_estimate":null,"consensus_revenue_actual":5413000000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":21474000299.405693,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149728,"accession_number":"0001022079-25-000154","cik":1022079,"company_name":"QUEST DIAGNOSTICS INC","ticker":"DGX","form_type":"8-K","filed_at":"2025-05-22T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Quest Diagnostics 2025 meeting: all director nominees elected, exec comp approved","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 10 director nominees elected; highest vote for Robert B. Carter (94.2M for), lowest for Timothy M. Ring (87.2M for).","Advisory vote on executive compensation passed: 85.9M for, 8.6M against.","Ratification of PwC as auditor for 2025 approved: 95.6M for, 6.9M against.","Stockholder proposal on special meetings defeated: 84.4M against, 9.5M for."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":21474000299.405693,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149727,"accession_number":"0001022079-25-000116","cik":1022079,"company_name":"QUEST DIAGNOSTICS INC","ticker":"DGX","form_type":"8-K","filed_at":"2025-04-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quest Diagnostics Q1 revenue up 12.1% to $2.65B, raises FY reported EPS guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 net revenues $2.65B (+12.1% YoY); reported diluted EPS $1.94 (+12.8%), adjusted diluted EPS $2.21 (+8.3%).","Organic revenue growth nearly 2.5%; requisition volume up 12.4%, organic volume down 0.9%.","Operating income $346M (13.0% margin); adjusted operating income $406M (15.3% margin).","Full year 2025 reported diluted EPS guidance raised to $8.62-$8.87 from prior $8.34-$8.59; adjusted EPS reaffirmed $9.55-$9.80.","Cash from operations guidance raised to ~$1.5B from ~$1.45B; capex unchanged at ~$500M."],"consensus_eps_estimate":null,"consensus_eps_actual":1.94,"consensus_revenue_estimate":null,"consensus_revenue_actual":2652000000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":21474000299.405693,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168759,"accession_number":"0000947871-25-000321","cik":1022079,"company_name":"QUEST DIAGNOSTICS INC","ticker":"DGX","form_type":"8-K","filed_at":"2025-03-19T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Quest Diagnostics holds Investor Day; strategic presentations on innovation, operations, and financial outlook","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["CEO Jim Davis presented on driving sustainable growth and delivering long-term value.","Karthik Kuppusamy discussed diagnostic innovation as a growth driver.","Cathy Doherty and Alex Louis presented on improving quality, experiences, and productivity.","CFO Sam Samad outlined long-term financial outlook; specific numbers not available from exhibits."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":21474000299.405693,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168758,"accession_number":"0000947871-25-000317","cik":1022079,"company_name":"QUEST DIAGNOSTICS INC","ticker":"DGX","form_type":"8-K","filed_at":"2025-03-19T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Quest Diagnostics provides long-term outlook: 4-5% revenue CAGR; reaffirms FY2025 guidance but notes Q1 weather headwind","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Long-term outlook: revenue CAGR 4-5%, adjusted EPS CAGR 7-9% beyond 2025.","Reaffirms FY2025 guidance: revenue $10.70B-$10.85B, adjusted EPS $9.55-$9.80.","Q1 2025 weather headwind of ~$25M revenue and ~$0.10 EPS expected.","Strategic initiatives include Invigorate productivity (3% annual savings) and Project Nova IT modernization.","Double-digit growth targeted in advanced diagnostics: oncology, cardiometabolic, brain health, others."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":21474000299.405693,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168757,"accession_number":"0001022079-25-000008","cik":1022079,"company_name":"QUEST DIAGNOSTICS INC","ticker":"DGX","form_type":"8-K","filed_at":"2025-01-30T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Quest Diagnostics Q4 revenue $2.62B (+14.5%), adjusted EPS $2.23 (+3.7%); raises dividend 6.7% to $0.80","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $2.62B (+14.5% YoY); reported diluted EPS $1.95 (+14.7%); adjusted diluted EPS $2.23 (+3.7%).","Full year 2024 revenue $9.87B (+6.7%); reported EPS $7.69 (+2.7%); adjusted EPS $8.93 (+2.5%).","FY2025 guidance: revenue $10.70-10.85B; reported EPS $8.34-8.59; adjusted EPS $9.55-9.80; cash ops ~$1.45B.","Quarterly dividend raised 6.7% to $0.80 ($3.20 annual), payable Apr 21, 2025 to holders of record Apr 7, 2025.","Completed 8 acquisitions in 2024 (including LifeLabs); extended health plan access to >90% of in-network lives."],"consensus_eps_estimate":null,"consensus_eps_actual":7.69,"consensus_revenue_estimate":null,"consensus_revenue_actual":9872000000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":21474000299.405693,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":185885,"accession_number":"0001022079-24-000187","cik":1022079,"company_name":"QUEST DIAGNOSTICS INC","ticker":"DGX","form_type":"8-K","filed_at":"2024-10-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quest Diagnostics Q3 revenue +8.5% to $2.49B, raises FY revenue guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenue $2.49B (+8.5% YoY); reported EPS $1.99 (+1.5%); adjusted EPS $2.30 (+3.6%).","Organic revenue growth 4.2%; revenue per requisition +3.3%, volume +5.5%.","FY2024 revenue guidance raised to $9.80-9.85B (from $9.50-9.58B); adjusted EPS guidance unchanged at $8.85-8.95.","Hurricane Milton expected to reduce Q4 revenue by ~$15M and EPS by ~$0.08.","CEO cites customer wins and acquisitions including LifeLabs; 8 acquisitions targeted by year-end."],"consensus_eps_estimate":null,"consensus_eps_actual":5.74,"consensus_revenue_estimate":null,"consensus_revenue_actual":7251000000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":21474000299.405693,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":202452,"accession_number":"0001022079-24-000173","cik":1022079,"company_name":"QUEST DIAGNOSTICS INC","ticker":"DGX","form_type":"8-K","filed_at":"2024-08-29T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Quest Diagnostics closes LifeLabs acquisition; terms not disclosed","summary_kind":"llm","event_type":"m_and_a","confidence":"low","bullets":["Acquisition of LifeLabs Inc., a Canadian lab diagnostics and digital health company, closed on August 26, 2024.","Deal was originally announced on July 2, 2024 via equity purchase agreement with Borealis Infrastructure and others.","No purchase price, financing details, or expected synergies provided in this filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":21474000299.405693,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":202451,"accession_number":"0001104659-24-090867","cik":1022079,"company_name":"QUEST DIAGNOSTICS INC","ticker":"DGX","form_type":"8-K","filed_at":"2024-08-19T23:59:59+00:00","items":["1.01","5.03","8.01","9.01"],"status":"ready","headline":"Quest Diagnostics prices $1.85B in senior notes to fund LifeLabs acquisition","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $400M at 4.600% due 2027, $600M at 4.625% due 2029, $850M at 5.000% due 2034.","Net proceeds to fund LifeLabs purchase price and related costs, plus general corporate purposes.","2027 and 2029 notes subject to special mandatory redemption at 101% if LifeLabs deal not completed.","2034 notes will remain outstanding even if LifeLabs acquisition is not consummated.","By-laws amended to provide officer exculpation as permitted by Delaware law."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":21474000299.405693,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":202450,"accession_number":"0001022079-24-000153","cik":1022079,"company_name":"QUEST DIAGNOSTICS INC","ticker":"DGX","form_type":"8-K","filed_at":"2024-07-23T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quest Diagnostics beats Q2 estimates, raises full-year guidance; announces four acquisitions","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenues $2.397B (+2.5% YoY); reported EPS $2.03 (-1% YoY), adjusted EPS $2.35 (+2.2% YoY)","Full-year 2024 revenue guidance raised to $9.50-9.58B; adjusted EPS raised to $8.80-9.00","Announces four acquisitions: LifeLabs (pending), Allina Health, OhioHealth outreach labs, PathAI Diagnostics (completed)","Base business revenue growth ~4%; driven by new customers, advanced diagnostics, healthcare utilization","Cash from ops guided ~$1.3B; capex ~$420M; both unchanged from prior guidance"],"consensus_eps_estimate":null,"consensus_eps_actual":3.75,"consensus_revenue_estimate":null,"consensus_revenue_actual":4763000000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":21474000299.405693,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":202449,"accession_number":"0000947871-24-000587","cik":1022079,"company_name":"QUEST DIAGNOSTICS INC","ticker":"DGX","form_type":"8-K","filed_at":"2024-07-03T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Quest Diagnostics to acquire LifeLabs from OMERS for C$1.35B (~US$985M)","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Cash purchase price of ~C$1.35B (US$985M) including net debt, funded with cash and debt.","LifeLabs generates ~C$970M (US$710M) annual revenue; deal slightly dilutive to GAAP EPS but accretive to adjusted EPS in first 12 months.","LifeLabs will retain its brand, Canadian HQ, and management; Quest to provide expertise and resources.","Closing expected by end of 2024, subject to Canadian regulatory approvals and key customer consents.","LifeLabs has >6,500 employees and is a leading Canadian community lab; existing reference relationship with Quest."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":21474000299.405693,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":218585,"accession_number":"0001022079-24-000138","cik":1022079,"company_name":"QUEST DIAGNOSTICS INC","ticker":"DGX","form_type":"8-K","filed_at":"2024-05-21T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Quest Diagnostics elects FedEx CIO Robert B. Carter to board; board now 10 members","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Robert B. Carter, EVP and CIO of FedEx, elected to Quest's Board effective May 16, 2024.","Carter also serves as Co-President and Co-CEO of FedEx Services; will step down from FedEx in June 2024.","Carter has technology and cybersecurity expertise; serves on New York Life board and previously First Horizon and Saks.","Board determined Carter is independent under NYSE standards; committee assignments pending.","Carter will receive standard non-employee director compensation as per Quest's practices."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":21474000299.405693,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":218584,"accession_number":"0001022079-24-000133","cik":1022079,"company_name":"QUEST DIAGNOSTICS INC","ticker":"DGX","form_type":"8-K","filed_at":"2024-05-21T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Quest Diagnostics shareholders approve officer exculpation, elect directors at annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Officer exculpation amendment approved with 80.2M for, 13.0M against; effective May 20, 2024.","All nine director nominees elected; vote totals ranged from 85.3M (Gary Pfeiffer) to 92.8M (Tracey Doi).","Advisory say-on-pay approved with 82.5M for, 10.6M against, 0.4M abstain.","Ratification of PricewaterhouseCoopers as auditor for 2024 approved with 96.5M for, 5.6M against.","Shareholder proposal on climate risk/science-based targets not approved; 39.1M for, 53.7M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":21474000299.405693,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":218583,"accession_number":"0001022079-24-000096","cik":1022079,"company_name":"QUEST DIAGNOSTICS INC","ticker":"DGX","form_type":"8-K","filed_at":"2024-04-23T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quest Diagnostics Q1 revenue $2.37B (+1.5% YoY); raises full-year adjusted EPS to $8.72-$8.97","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $2.366B, up 1.5% YoY; base business revenue grew nearly 6%.","Reported diluted EPS $1.72 (down 3.4%); adjusted diluted EPS $2.04 (flat YoY).","Full-year 2024 guidance raised: revenue $9.40B-$9.48B, adjusted EPS $8.72-$8.97.","Invigorate initiative driving productivity; growth in brain, women's, and cardiometabolic health.","Cash from operations $154M (+64.8%); capex $104M."],"consensus_eps_estimate":null,"consensus_eps_actual":1.72,"consensus_revenue_estimate":null,"consensus_revenue_actual":2366000000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":21474000299.405693,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}